Our Deals

• 2018.11.12David Zou delivered a speech at Fintech Forum in Mexico City
• 2018.10.15Grandway advised Yantai China Pet Foods Co., Ltd. (Stock Code:002891) on its 100% acquisition of two New Zealand pet foods companies (Natural Pet Treat Company Limited and Zeal Pet Foods New Zealand L
• 2018.10.15Grandway advised Beyondsoft Corporation (Stock Code:002649) on its issuance of convertible corporate bond on Shenzhen Stock Exchange which received the approval from CSRC on October 15, 2018.
• 2018.09.17Grandway advised Yantai China Pet Foods Co., Ltd. (Stock Code:002891) on its issuance of convertible corporate bond on Shenzhen Stock Exchange which received the approval from CSRC on September 17, 20
• 2018.09.17Grandway advised VGRASS Fashion Co., Ltd. (Stock Code: 603518) on its issuance of convertible corporate bond on Shanghai Stock Exchange which received the approval of CSRC on September 17, 2018. VGRAS
• 2018.09.04Grandway advised on the IPO of Wuxi Shangji Automation Co., Ltd. which received its approval from CSRC on September 4, 2018. Wuxi Shangji Automation Co., Ltd. is in the high-end equipment manufacturin
• 2018.08.20Grandway advised Fujian Funeng Co.,Ltd. (Stock Code:600483) on its issuance of convertible corporate bond on Shanghai Stock Exchange which received the approval from CSRC on August 20, 2018.
• 2018.08.17Grandway advised the significant asset restructuring of Vcanbio Cell & Gene Engineering Corp., Ltd. (Stock Code: 600645).
• 2018.08.09Grandway advised China Merchants Group on its equity investment into Tianjin Pharmaceutical Research Institute.
• 2018.08.07Grandway advised on the IPO of Wuhan Bester Group Telecom Co., Ltd. (Stock Code: 603220) which received it is approval from CSRC on August 7, 2018 and listed on the Shanghai Stock Exchange on November
• 2018.07.16Grandway advised the formation of a private equity fund in Cayman Islands. The fund is managed by Goldbay Investment and Asset Management Limited.
• 2018.06.25Grandway advised the significant asset restructuring of Quantum Hi-Tech (China) Biological Co., Ltd (Stock Code:300149) .
• 2018.05.21Grandway advised William Blair & Co., a major U.S. investment bank and asset management company on its entering into the Chinese market.
• 2018.05.03Grandway advised Cefla on compliance matters of its subsidiaries in China.
• 2018.04.13Grandway advised the Material Assest Restructuring of Quantum Hi-Tech (China) Biological Co., Ltd stock code:300149) which received approval of CRSC on April 26, 2018
• 2018.04.11Grandway advised on the listing of Xianhe Co., Ltd. (Stock Code: 603733) on the Shanghai Stock Exchange on April 20, 2018. Xianhe Co., Ltd. Is in the business of specialty paper manufacturing business
• 2018.04.06Grandway advised the listing of WG Tech (Jiang Xi) Co., LTD (Stock Code:603773)on the Shanghai Stock Exchange on April 17, 2018.
• 2018.04.05Grandway advised on the IPO and listing of China Greatwall Securities Co., Ltd. ( Stock Code: 002939) which received its approval from CSRC on the Shenzhen Stock Exchange on October 26April 10, 2018.
• 2018.03.08Grandway advised on the public offering of a supply chain financial assets backed plan by BYD Group on the Shenzhen Stock Exchange on March 8, 2018. This is the first ABS product of this nature in the
• 2018.03.02Grandway advised the significant asset restructuring of Cnlight Co.,Ltd. (Stock Code:002076).